Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/18/2024 | $148.00 | Buy | HSBC Securities |
9/12/2024 | $130.00 | Equal Weight | Wells Fargo |
8/27/2024 | $153.00 | Buy | Redburn Atlantic |
1/4/2024 | $96.00 | Outperform | TD Cowen |
11/30/2023 | $91.00 → $94.00 | Outperform | Oppenheimer |
10/5/2023 | $75.00 | Outperform | Wolfe Research |
5/19/2023 | $69.00 | Buy | Citigroup |
3/2/2023 | $69.00 | Overweight | Barclays |
Board of FUJI SOFT Unanimously Supports KKR Second Tender Offer and Recommends Tender KKR, a leading global investment firm, announced today that in connection with the Second Tender Offer in its two-stage tender offer scheme (the "Tender Offer") for the common shares and share options of FUJI SOFT INCORPORATED ("FUJI SOFT" or the "Company"; TSE stock code 9749) through FK Co., Ltd. (the "Offeror"), an entity owned by investment funds managed by KKR, the Offeror has submitted an amendment statement ("Amendment Statement") to the Tender Offer Registration Statement that was submitted on November 20, 2024. The Amendment Statement was submitted due to the Offeror's decision to extend the e
Aiwyn, a trusted technology partner for top Certified Public Accounting ("CPA") firms, today announced the successful close of a $113M funding round. This landmark investment, led by leading global investment firm KKR and Bessemer Venture Partners underscores Aiwyn's leadership in the accounting technology sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219022365/en/ Today, Aiwyn serves 130 of the top 500 CPA firms as a leading provider of automation software designed to streamline the full revenue management lifecycle for accounting firms. Aiwyn's current product creates an exceptional client experience for CPA firms
Henry McVey: The Glass is Still Half Full for Investors KKR, a leading global investment firm, today released its 2025 Global Macro Outlook by Henry McVey, CIO of KKR's Balance Sheet and Head of Global Macro and Asset Allocation (GMAA). McVey and his team retain a Glass Half Full mentality heading into 2025, though they believe the bar is now higher to achieve strong absolute returns. They also note that while investors should expect lower returns and more volatility, the combination of stronger U.S. productivity, favorable technicals, robust nominal earnings growth, and lack of net issuance elicit confidence that more gains lie ahead for investors in 2025. Against this backdrop, McVe
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
HSBC Securities initiated coverage of KKR with a rating of Buy and set a new price target of $148.00
Wells Fargo initiated coverage of KKR with a rating of Equal Weight and set a new price target of $130.00
Redburn Atlantic initiated coverage of KKR with a rating of Buy and set a new price target of $153.00
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief Executive Officer and a member of the Board of Directors, effective immediately. The Board has also appointed Kieran Murphy as Chairman, effective as of the same date. Matt Gunnison will succeed Urs Spitz, under whose guidance Biosynth has achieved remarkable growth and strengthened its position in the life sciences sector. Urs Spitz will remain a member of the Board of Directors. "We are grateful to Urs for his significant contributions in shaping Biosynth into the innovative and thriving compa
New leadership and reorganization will foster the next chapter of growth and enhance business operations to best support evolving client and CRO partner needs on a global scale. MALVERN, Pa., Oct. 29, 2024 /PRNewswire/ -- Resolian, a leading global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials, today announced several leadership changes as the company expands its global footprint and operational capabilities. Rob Stachlewitz will join Resolian as Chief Executive Officer (CEO), while current CEO Pat Bennett will transition into the newly created role of Chief Business Officer and President of Scientific Affairs. In addition, the
Global Atlantic Financial Group ("Global Atlantic"), a leading insurance provider meeting the retirement and life insurance needs of individuals and institutions, today announced the appointment of Tim Bridgers as Head of Preneed Sales, effective immediately. In this role, Mr. Bridgers will oversee all aspects of Global Atlantic's preneed sales, including agency and funeral home relationships, as well as strategies for marketing, pricing, and product development. He succeeds Kelly Milberger, who is retiring after a distinguished career in the industry. Based in Wilmington, North Carolina, Mr. Bridgers joins Global Atlantic from Live Oak Bank, where he spent a decade in various leadership
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
10-Q - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
KKR today announced a monetization activity update for the period from October 1, 2024 to December 17, 2024. Based on information available to us as of today, with respect to the period through December 17, 2024, KKR's Asset Management segment has earned total realized performance income, including realized carried interest and realized incentive fees, and total realized investment income in excess of $725 million. Realized carried interest drove over half of our monetization activity quarter-to-date. The quarter-to-date monetization activity is driven by a combination of secondary sales and strategic transactions that have closed quarter-to-date, dividends and interest income, as well as i
FUJI SOFT's advisors, directors, and officers tendered ~90% of their share options Result means any plan to privatize FUJI SOFT will require KKR's support KKR, a leading global investment firm, today announced that in connection with its two-stage tender offer scheme (the "Tender Offer") for the common shares and share options of FUJI SOFT INCORPORATED (TSE stock code 9749; "FUJI SOFT") through FK Co., Ltd. (the "Offeror"), the Offeror, an entity owned by investment funds managed by KKR, completed the first of the two planned tender offers ("First Tender Offer") on November 5. With the completion of the First Tender Offer, the Offeror will become the largest shareholder of FUJI SOFT,
PHILADELPHIA and NEW YORK, Nov. 6, 2024 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended September 30, 2024, and that its board of directors previously, on October 8, 2024, declared a fourth quarter 2024 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended September 30, 2024(1) Net investment income of $0.77 per share, compared to $0.77 per share for the quarter ended June 30, 2024Adjusted net investment income(2) of $0.74 per share, compared to $0.75